| 1. |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
| 2. |
姚一菲, 孫可欣, 鄭榮壽. 《2022全球癌癥統計報告》解讀: 中國與全球對比. 中國普外基礎與臨床雜志, 2024, 31(7): 769-780.
|
| 3. |
Pensabene M, Calabrese A, von Arx C, et al. Cancer genetic counselling for hereditary breast cancer in the era of precision oncology. Cancer Treat Rev, 2024, 125: 102702. doi: 10.1016/j.ctrv.2024.102702.
|
| 4. |
Haupt S, Caramia F, Klein SL, et al. Sex disparities matter in cancer development and therapy. Nat Rev Cancer, 2021, 21(6): 393-407.
|
| 5. |
Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman’s predicted breast cancer risk? J Clin Oncol, 2006, 24(12): 1823-1830.
|
| 6. |
Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol, 2012, 13(8): 790-801.
|
| 7. |
Kim J, Harper A, McCormack V, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med, 2025, 31(4): 1154-1162.
|
| 8. |
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 ?513 ?025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet, 2018, 391(10125): 1023-1075.
|
| 9. |
US Preventive Services Task Force; Nicholson WK, Silverstein M, et al. Screening for breast cancer: US Preventive Services Task Force Recommendation Statement. JAMA, 2024, 331(22): 1918-1930.
|
| 10. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| 11. |
Caswell-Jin JL, Sun LP, Munoz D, et al. Analysis of breast cancer mortality in the US-1975 to 2019. JAMA, 2024, 331(3): 233-241.
|
| 12. |
Bodmer A, Feller A, Bordoni A, et al. Breast cancer in younger women in Switzerland 1996-2009: a longitudinal population-based study. Breast, 2015, 24(2): 112-117.
|
| 13. |
Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China. Lancet Oncol, 2014, 15(7): e279-e289.
|
| 14. |
Youlden DR, Cramb SM, Yip CH, et al. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med, 2014, 11(2): 101-115.
|
| 15. |
Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond), 2021, 41(11): 1183-1194.
|
| 16. |
Gu H, Wang R, Beeraka NM, et al. Global burden and trends of breast cancer: GLOBOCAN 2022 estimates of incidence and mortality in 185 countries. Chin Med J (Engl), 2026, 139(3): 404-414.
|
| 17. |
WHO Scientific Group on Research on the Menopause in the 1990s (1994: Geneva, Switzerland) & World Health Organization (1996). Research on the menopause in the 1990s: report of a WHO scientific group. World Health Organization. (1994-06-17)[2026-04-29]. https://iris.who.int/handle/10665/41841.
|
| 18. |
Heer E, Harper A, Escandor N, et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health, 2020, 8(8): e1027-e1037.
|
| 19. |
Jedy-Agba E, McCormack V, Adebamowo C, et al. Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health, 2016, 4(12): e923-e935.
|
| 20. |
鄔昊, 呂青. 全球及中國乳腺癌的流行病學趨勢及防控啟示: 2018–2022年《全球癌癥統計報告》解讀. 中國普外基礎與臨床雜志, 2024, 31(7): 796-802.
|
| 21. |
Al Hasan SM, Bennett DL, Toriola AT. Screening programmes and breast cancer mortality: an observational study of 194 countries. Bull World Health Organ, 2025, 103(8): 470-483.
|
| 22. |
Zhang L, Mosquera I, Lucas E, et al. CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs. Nat Med, 2023, 29(5): 1135-1145.
|
| 23. |
Sun K, Lei L, Zheng R, et al. Trends in incidence rates, mortality rates, and age-period-cohort effects of female breast cancer - China, 2003-2017. China CDC Wkly, 2023, 5(15): 340-346.
|
| 24. |
Henderson JT, Webber EM, Weyrich MS, et al. Screening for breast cancer: evidence report and systematic review for the US preventive services task force. JAMA, 2024, 331(22): 1931-1946.
|
| 25. |
Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US preventive services task force. JAMA, 2024, 331(22): 1947-1960.
|
| 26. |
Qaseem A, Lin JS, Mustafa RA, et al. Screening for breast cancer in Average-Risk women: a Guidance Statement from the American College of Physicians. Ann Intern Med, 2019, 170(8): 547-560.
|
| 27. |
Katsika L, Boureka E, Kalogiannidis I, et al. Screening for breast cancer: a comparative review of guidelines. Life (Basel), 2024, 14(6): 777. doi: 10.3390/life14060777.
|